• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction.

作者信息

Shah Sanjiv J

机构信息

Division of Cardiology, Department of Medicine, and Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Eur Heart J. 2022 May 21;43(20):1952-1954. doi: 10.1093/eurheartj/ehac121.

DOI:10.1093/eurheartj/ehac121
PMID:35301541
Abstract
摘要

相似文献

1
BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction.脑钠肽：射血分数保留的心力衰竭中并非完美的生物标志物。
Eur Heart J. 2022 May 21;43(20):1952-1954. doi: 10.1093/eurheartj/ehac121.
2
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
3
Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction.射血分数保留和降低的心力衰竭中的非利钠肽生物标志物。
Biomark Med. 2018 Jul;12(7):783-797. doi: 10.2217/bmm-2017-0376. Epub 2018 Jun 5.
4
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.在射血分数降低的心力衰竭患者中，可溶性ST2升高比利钠肽更能预测长期心血管死亡。
Int J Cardiol. 2014;172(1):e250-2. doi: 10.1016/j.ijcard.2013.12.101. Epub 2014 Jan 4.
5
Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.射血分数保留的心力衰竭患者与射血分数降低的心力衰竭患者中B型利钠肽水平升高的不同含义。
Echocardiography. 2015 Apr;32(4):623-9. doi: 10.1111/echo.12707. Epub 2014 Aug 13.
6
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.利钠肽与射血分数保留的心力衰竭患者心血管预后的相关性：TOPCAT 随机临床试验的二次分析。
JAMA Cardiol. 2018 Oct 1;3(10):1000-1005. doi: 10.1001/jamacardio.2018.2568.
7
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.射血分数保留的心力衰竭急性入院后利钠肽的变化：一个可行的替代试验终点？来自前瞻性凯伦研究的报告。
Int J Cardiol. 2017 Jan 1;226:65-70. doi: 10.1016/j.ijcard.2016.10.035. Epub 2016 Oct 17.
8
Novel biomarkers in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的新型生物标志物。
Heart Fail Clin. 2014 Jul;10(3):471-9. doi: 10.1016/j.hfc.2014.04.005.
9
Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.描述射血分数保留和降低的心衰：影像学和血浆生物标志物方法。
PLoS One. 2020 Apr 29;15(4):e0232280. doi: 10.1371/journal.pone.0232280. eCollection 2020.
10
Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot?通过治疗靶向调节心力衰竭中的利钠肽水平：“X”真的是关键所在吗？
Curr Heart Fail Rep. 2019 Dec;16(6):250-256. doi: 10.1007/s11897-019-00441-2.

引用本文的文献

1
Predictive value of baseline serum sST2 and BNP levels for treatment efficacy in patients with heart failure.基线血清可溶性ST2和脑钠肽水平对心力衰竭患者治疗疗效的预测价值。
Am J Transl Res. 2025 Jun 15;17(6):4484-4492. doi: 10.62347/KQWC4381. eCollection 2025.
2
High-Complexity Questions and Their Answers for Everyday Heart Failure.日常心力衰竭的高复杂性问题及其答案
J Clin Med. 2025 Jun 5;14(11):3993. doi: 10.3390/jcm14113993.
3
B-type natriuretic peptide efficacy compared to fragmented QRS for diastolic dysfunction screening in patients with type 2 diabetes.
与碎裂QRS波相比，B型利钠肽在2型糖尿病患者舒张功能障碍筛查中的疗效
World J Diabetes. 2025 Apr 15;16(4):103551. doi: 10.4239/wjd.v16.i4.103551.
4
Clinical Insights from Proteomics in Heart Failure.心力衰竭蛋白质组学的临床见解
Curr Heart Fail Rep. 2025 Mar 10;22(1):12. doi: 10.1007/s11897-025-00698-w.
5
Advanced Machine Learning to Predict Coronary Artery Disease Severity in Patients with Premature Myocardial Infarction.运用先进机器学习预测早发心肌梗死患者的冠状动脉疾病严重程度
Rev Cardiovasc Med. 2025 Jan 16;26(1):26102. doi: 10.31083/RCM26102. eCollection 2025 Jan.
6
Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay.射血分数保留的心力衰竭与心房颤动：流行病学、病理生理学及诊断的相互关系
Heart Fail Rev. 2025 Jan 24. doi: 10.1007/s10741-025-10488-0.
7
The Implication of NT-proBNP in the Assessment of the Clinical Phenotype of Patients with Type 2 Diabetes Mellitus, Without Established Cardiovascular Disease.N末端B型利钠肽原在评估无确诊心血管疾病的2型糖尿病患者临床表型中的意义
Biomedicines. 2024 Nov 27;12(12):2718. doi: 10.3390/biomedicines12122718.
8
Pathophysiology of Congestion in Heart Failure: A Contemporary Review.心力衰竭中充血的病理生理学：当代综述
Card Fail Rev. 2024 Sep 25;10:e13. doi: 10.15420/cfr.2024.07. eCollection 2024.
9
Imaging Advances in Heart Failure.心力衰竭的影像学进展
Card Fail Rev. 2024 Sep 16;10:e12. doi: 10.15420/cfr.2023.10. eCollection 2024.
10
Subclinical Left Ventricular Dysfunction over Seven-Year Follow-Up in Type 2 Diabetes Patients without Cardiovascular Diseases.2型糖尿病无心血管疾病患者七年随访中的亚临床左心室功能障碍
Biomedicines. 2024 Sep 5;12(9):2031. doi: 10.3390/biomedicines12092031.